BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 32601305)

  • 1. ACOD1 in immunometabolism and disease.
    Wu R; Chen F; Wang N; Tang D; Kang R
    Cell Mol Immunol; 2020 Aug; 17(8):822-833. PubMed ID: 32601305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial ACOD1/IRG1 in infection and sterile inflammation.
    Wu R; Kang R; Tang D
    J Intensive Med; 2022 Apr; 2(2):78-88. PubMed ID: 36789185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous itaconate is not required for particulate matter-induced NRF2 expression or inflammatory response.
    Sun KA; Li Y; Meliton AY; Woods PS; Kimmig LM; Cetin-Atalay R; Hamanaka RB; Mutlu GM
    Elife; 2020 Apr; 9():. PubMed ID: 32255424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The STING1-MYD88 complex drives ACOD1/IRG1 expression and function in lethal innate immunity.
    Chen F; Wu R; Liu J; Kang R; Li J; Tang D
    iScience; 2022 Jul; 25(7):104561. PubMed ID: 35769880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dual Role of ACOD1 in Inflammation.
    Wu R; Liu J; Tang D; Kang R
    J Immunol; 2023 Aug; 211(4):518-526. PubMed ID: 37549395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acod1/itaconate activates Nrf2 in pulmonary microvascular endothelial cells to protect against the obesity-induced pulmonary microvascular endotheliopathy.
    Zhu L; Wu Z; Liu Y; Ming Y; Xie P; Jiang M; Qi Y
    Respir Res; 2024 May; 25(1):205. PubMed ID: 38730297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aconitate decarboxylase 1 is a mediator of polymicrobial sepsis.
    Wu R; Liu J; Wang N; Zeng L; Yu C; Chen F; Wang H; Billiar TR; Jiang J; Tang D; Kang R
    Sci Transl Med; 2022 Aug; 14(659):eabo2028. PubMed ID: 36001682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages inhibit Coxiella burnetii by the ACOD1-itaconate pathway for containment of Q fever.
    Kohl L; Siddique MNAA; Bodendorfer B; Berger R; Preikschat A; Daniel C; Ölke M; Liebler-Tenorio E; Schulze-Luehrmann J; Mauermeir M; Yang KT; Hayek I; Szperlinski M; Andrack J; Schleicher U; Bozec A; Krönke G; Murray PJ; Wirtz S; Yamamoto M; Schatz V; Jantsch J; Oefner P; Degrandi D; Pfeffer K; Mertens-Scholz K; Rauber S; Bogdan C; Dettmer K; Lührmann A; Lang R
    EMBO Mol Med; 2023 Feb; 15(2):e15931. PubMed ID: 36479617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1.
    Zhao Y; Liu Z; Liu G; Zhang Y; Liu S; Gan D; Chang W; Peng X; Sung ES; Gilbert K; Zhu Y; Wang X; Zeng Z; Baldwin H; Ren G; Weaver J; Huron A; Mayberry T; Wang Q; Wang Y; Diaz-Rubio ME; Su X; Stack MS; Zhang S; Lu X; Sheldon RD; Li J; Zhang C; Wan J; Lu X
    Cell Metab; 2023 Oct; 35(10):1688-1703.e10. PubMed ID: 37793345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aconitate decarboxylase 1 suppresses cerebral ischemia-reperfusion injury in mice.
    Vigil TM; Frieler RA; Kilpatrick KL; Wang MM; Mortensen RM
    Exp Neurol; 2022 Jan; 347():113902. PubMed ID: 34699789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of immune cell signaling by the immuno-metabolite itaconate.
    Lang R; Siddique MNAA
    Front Immunol; 2024; 15():1352165. PubMed ID: 38487538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aconitate decarboxylase 1/itaconate pathway modulates immune dysregulation and associates with cardiovascular disease markers in SLE.
    Patiño-Martinez E; Nakabo S; Jiang K; Carmona-Rivera C; Tsai WL; Claybaugh D; Yu ZX; Romero A; Bohrnsen E; Schwarz B; Solís-Barbosa MA; Blanco LP; Naqi M; Temesgen-Oyelakim Y; Davis M; Manna Z; Mehta N; Naz F; Brooks S; dell'Orso S; Hasni S; Kaplan MJ
    medRxiv; 2024 Feb; ():. PubMed ID: 38605883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the ACOD1-itaconate axis stabilizes atherosclerotic plaques.
    Harber KJ; Neele AE; van Roomen CP; Gijbels MJ; Beckers L; Toom MD; Schomakers BV; Heister DA; Willemsen L; Griffith GR; de Goede KE; van Dierendonck XA; Reiche ME; Poli A; L-H Mogensen F; Michelucci A; Verberk SG; de Vries H; van Weeghel M; Van den Bossche J; de Winther MP
    Redox Biol; 2024 Apr; 70():103054. PubMed ID: 38309122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acod1 expression in cancer cells promotes immune evasion through the generation of inhibitory peptides.
    Schofield JH; Longo J; Sheldon RD; Albano E; Ellis AE; Hawk MA; Murphy S; Duong L; Rahmy S; Lu X; Jones RG; Schafer ZT
    Cell Rep; 2024 Apr; 43(4):113984. PubMed ID: 38520689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aconitate decarboxylase 1 participates in the control of pulmonary Brucella infection in mice.
    Demars A; Vitali A; Comein A; Carlier E; Azouz A; Goriely S; Smout J; Flamand V; Van Gysel M; Wouters J; Abendroth J; Edwards TE; Machelart A; Hoffmann E; Brodin P; De Bolle X; Muraille E
    PLoS Pathog; 2021 Sep; 17(9):e1009887. PubMed ID: 34525130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid positions near the active site determine the reduced activity of human ACOD1 compared to murine ACOD1.
    Chen F; Yalcin I; Zhao M; Chen C; Blankenfeldt W; Pessler F; Büssow K
    Sci Rep; 2023 Jun; 13(1):10360. PubMed ID: 37365251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism.
    Chen F; Elgaher WAM; Winterhoff M; Büssow K; Waqas FH; Graner E; Pires-Afonso Y; Casares Perez L; de la Vega L; Sahini N; Czichon L; Zobl W; Zillinger T; Shehata M; Pleschka S; Bähre H; Falk C; Michelucci A; Schuchardt S; Blankenfeldt W; Hirsch AKH; Pessler F
    Nat Metab; 2022 May; 4(5):534-546. PubMed ID: 35655026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy.
    Chen YJ; Li GN; Li XJ; Wei LX; Fu MJ; Cheng ZL; Yang Z; Zhu GQ; Wang XD; Zhang C; Zhang JY; Sun YP; Saiyin H; Zhang J; Liu WR; Zhu WW; Guan KL; Xiong Y; Yang Y; Ye D; Chen LL
    Sci Adv; 2023 Apr; 9(17):eadg0654. PubMed ID: 37115931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases.
    Shi X; Zhou H; Wei J; Mo W; Li Q; Lv X
    Redox Biol; 2022 Dec; 58():102553. PubMed ID: 36459716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of
    Chen F; Lukat P; Iqbal AA; Saile K; Kaever V; van den Heuvel J; Blankenfeldt W; Büssow K; Pessler F
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20644-20654. PubMed ID: 31548418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.